JP2003510359A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510359A5
JP2003510359A5 JP2001527795A JP2001527795A JP2003510359A5 JP 2003510359 A5 JP2003510359 A5 JP 2003510359A5 JP 2001527795 A JP2001527795 A JP 2001527795A JP 2001527795 A JP2001527795 A JP 2001527795A JP 2003510359 A5 JP2003510359 A5 JP 2003510359A5
Authority
JP
Japan
Prior art keywords
anilino
triazole
methyl
benzylthio
ylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001527795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510359A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/026951 external-priority patent/WO2001024796A1/en
Publication of JP2003510359A publication Critical patent/JP2003510359A/ja
Publication of JP2003510359A5 publication Critical patent/JP2003510359A5/ja
Pending legal-status Critical Current

Links

JP2001527795A 1999-10-01 2000-09-29 化合物および方法 Pending JP2003510359A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15728699P 1999-10-01 1999-10-01
US60/157,286 1999-10-01
PCT/US2000/026951 WO2001024796A1 (en) 1999-10-01 2000-09-29 1,2,4-triazole derivatives, composition, process of making and methods of use

Publications (2)

Publication Number Publication Date
JP2003510359A JP2003510359A (ja) 2003-03-18
JP2003510359A5 true JP2003510359A5 (https=) 2007-11-22

Family

ID=22563095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001527795A Pending JP2003510359A (ja) 1999-10-01 2000-09-29 化合物および方法

Country Status (5)

Country Link
US (1) US7304082B2 (https=)
EP (1) EP1223932A4 (https=)
JP (1) JP2003510359A (https=)
AU (1) AU7989400A (https=)
WO (1) WO2001024796A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508841A (ja) * 2001-03-29 2005-04-07 スミスクライン・ビーチャム・コーポレイション 化合物および方法
US20050222212A1 (en) * 2002-03-27 2005-10-06 Marino Joseph P Compounds and methods
WO2004014881A2 (en) * 2002-08-09 2004-02-19 Astra Zeneca Ab '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
FR2862060A1 (fr) * 2003-11-06 2005-05-13 Galderma Res & Dev Procede de synthese en phase solide de composes de types sulfures de diaryle.
US8063083B2 (en) * 2006-05-25 2011-11-22 Synta Pharmaceuticals Corp. Method for treating non-Hodgkin's lymphoma
JP2010531896A (ja) * 2007-06-26 2010-09-30 チルドレンズ メディカル センター コーポレーション 治療的投与のためのMetAP−2阻害剤ポリマーソーム
WO2013055385A2 (en) 2011-10-03 2013-04-18 Zafgen Corporation Methods of treating age related disorders
MX337575B (es) 2009-10-09 2016-03-10 Zafgen Corp Compuestos de sulfona y métodos para lafabricación y uso de éstos.
US8815309B2 (en) 2010-01-08 2014-08-26 Zafgen, Inc. Methods of treating a subject with benign prostate hyperplasia
US20130023513A1 (en) 2010-01-12 2013-01-24 Hughes Thomas E Methods and Compositions for Treating Cardiovascular Disorders
US20130266578A1 (en) 2010-04-07 2013-10-10 Thomas E. Hughes Methods of treating an overweight subject
EP2560640A1 (en) 2010-04-19 2013-02-27 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
AU2011281037B2 (en) * 2010-07-22 2014-11-27 Zafgen, Inc. Tricyclic compounds and methods of making and using same
WO2012064928A1 (en) 2010-11-10 2012-05-18 Zafgen Corporation Methods and compositions for treating thyroid hormone related disorders
US20130316994A1 (en) 2010-11-29 2013-11-28 Zafgen, Inc. Methods of Reducing Risk of Hepatobiliary Dysfunction During Rapid Weight Loss with METAP-2 Inhibitors
US9189078B2 (en) 2010-12-20 2015-11-17 Apple Inc. Enhancing keycap legend visibility with optical components
WO2012103333A1 (en) 2011-01-26 2012-08-02 Zafgen Corporation Tetrazole compounds and methods of making and using same
US9242997B2 (en) 2011-05-06 2016-01-26 Zafgen, Inc. Tricyclic pyrazole sulphonamide compunds and methods of making and using same
CN103748094B (zh) 2011-05-06 2016-06-29 扎夫根股份有限公司 三环磺酰胺化合物及其制备和使用方法
SG194812A1 (en) 2011-05-06 2013-12-30 Zafgen Inc Partially saturated tricyclic compounds and methods of making and using same
CA2853799A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
JP2014534228A (ja) 2011-11-02 2014-12-18 シンタ ファーマシューティカルズ コーポレーション 白金含有剤とhsp90阻害剤の組合せ療法
US9402831B2 (en) 2011-11-14 2016-08-02 Synta Pharmaceutical Corp. Combination therapy of HSP90 inhibitors with BRAF inhibitors
WO2013109735A1 (en) 2012-01-18 2013-07-25 Zafgen, Inc. Tricyclic sulfone compounds and methods of making and using same
BR112014017673A8 (pt) 2012-01-18 2017-07-11 Zafgen Inc Compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
EP2846792B1 (en) 2012-05-08 2018-08-15 Zafgen, Inc. Treating hypothalamic obesity with metap2 inhibitors
WO2013169860A1 (en) 2012-05-09 2013-11-14 Zafgen, Inc. Fumigillol type compounds and methods of making and using same
BR112015010196A2 (pt) 2012-11-05 2017-07-11 Zafgen Inc métodos de tratar doença do fígado
MX2015005733A (es) 2012-11-05 2016-02-10 Zafgen Inc Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
KR20150079952A (ko) 2012-11-05 2015-07-08 자프겐 인크. 트리시클릭 화합물 및 그의 제조 및 사용 방법
US9597309B2 (en) 2013-03-14 2017-03-21 Zafgen, Inc. Methods of treating renal disease and other disorders
WO2015089800A1 (en) 2013-12-19 2015-06-25 Eli Lilly And Company Fluorophenyl pyrazol compounds
CA2950357A1 (en) * 2014-06-12 2015-12-17 Universite De Lille 2 Droit Et Sante Imidazol- or 1,2,4-triazol-derivatives and their use
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
CR20200588A (es) * 2018-05-04 2021-06-24 Inflazome Ltd Compuestos novedosos

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55120571A (en) * 1979-03-02 1980-09-17 Glaxo Group Ltd Heterocyclic derivative
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
HU191475B (en) * 1982-09-01 1987-02-27 Gyogyszerkutato Intezet Process for producing new acylized 1,2,4-triazole derivatives
US4760448A (en) * 1987-05-04 1988-07-26 Sencore, Inc. Method of measuring amplitude variations of a video carrier and apparatus therefor
JPH01160972A (ja) * 1987-12-18 1989-06-23 Tsumura & Co 1,2,4−トリアゾール誘導体及びそれを有効成分として含有する抗潰瘍剤
DE4142366A1 (de) 1991-07-15 1993-06-24 Thomae Gmbh Dr K Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9207396D0 (en) 1992-04-03 1992-05-13 Merck Sharp & Dohme Therapeutic agents
DE4424787A1 (de) 1994-07-14 1996-01-18 Bayer Ag Substituierte Aryliminoheterocyclen
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
CZ160597A3 (en) * 1994-11-29 1997-10-15 Lonza Ag Process for preparing active metallocenyl phosphines
US5798374A (en) * 1995-06-07 1998-08-25 Sugen Inc. Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
US20020168761A1 (en) * 2000-01-24 2002-11-14 Gour Barbara J. Peptidomimetic modulators of cell adhesion
US5760246A (en) * 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
US6207704B1 (en) * 1997-06-09 2001-03-27 Massachusetts Institute Of Technology Type 2 methionine aminopeptidase [MetAP2] inhibitors and uses thereof
DE19922443A1 (de) * 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
DE19921567A1 (de) * 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
WO2001036404A1 (en) 1999-11-19 2001-05-25 Smithkline Beecham Corporation Compounds and methods
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
WO2001078723A1 (en) * 2000-04-12 2001-10-25 Smithkline Beecham Corporation Compounds and methods
AU2001278951A1 (en) 2000-07-19 2002-01-30 Smith Kline Beecham Corporation Compounds and methods
EP1379241A1 (en) * 2001-03-29 2004-01-14 SmithKline Beecham Corporation Compounds and methods
WO2002078696A1 (en) * 2001-03-29 2002-10-10 Smithkline Beecham Corporation Compounds and methods
WO2002081415A2 (en) 2001-04-03 2002-10-17 Smithkline Beecham Corporation Method for inhibiting metap2
EP1434772A4 (en) * 2001-10-12 2005-05-04 Smithkline Beecham Corp CONNECTIONS AND METHODS
AU2002359694A1 (en) 2001-12-14 2003-06-30 Smithkline Beecham Corporation Compounds and methods
JP2003281388A (ja) * 2002-03-25 2003-10-03 Hitachi Ltd 自動取引装置
US20050222212A1 (en) * 2002-03-27 2005-10-06 Marino Joseph P Compounds and methods
US20040116490A1 (en) * 2002-03-28 2004-06-17 Marino Jr. Joseph P. Compounds and methods

Similar Documents

Publication Publication Date Title
JP2003510359A5 (https=)
RU2006127575A (ru) Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2019077725A5 (https=)
JP2020516671A5 (https=)
JP2022096662A5 (https=)
JP2007523181A5 (https=)
RU2003118448A (ru) Производные замещенного триазолдиамина и их применение в качестве ингибиторов киназы
JP2005511608A5 (https=)
US20090054491A1 (en) Use
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2010505809A5 (https=)
JP2009519965A5 (https=)
JP2007523182A5 (https=)
JP2014511869A5 (https=)
RU2004117545A (ru) Аминопиримидины и пиридины
JP2007511485A5 (https=)
JP2006503081A5 (https=)
JP2006524686A5 (https=)
RU2009111113A (ru) Мидуляторы mglur5
JP2006506380A5 (https=)
JP2006507355A5 (https=)
JP2011527675A5 (https=)
JP2002505286A5 (https=)
JP2004525184A5 (https=)
JP2004524279A5 (https=)